RZ402

RZ402 · Rezolute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RZ402, covering 2025-10-03 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME) [Phase 2]